Last reviewed · How we verify
Bronchial fibroscopy — Competitive Intelligence Brief
phase 2
Respiratory
Biologic
Live · refreshed every 30 min
Target snapshot
Bronchial fibroscopy (Bronchial fibroscopy) — CMC Ambroise Paré. Bronchial fibroscopy is a diagnostic procedure that uses a flexible tube with a camera and light to visually examine the airways and lungs.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bronchial fibroscopy TARGET | Bronchial fibroscopy | CMC Ambroise Paré | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bronchial fibroscopy CI watch — RSS
- Bronchial fibroscopy CI watch — Atom
- Bronchial fibroscopy CI watch — JSON
- Bronchial fibroscopy alone — RSS
Cite this brief
Drug Landscape (2026). Bronchial fibroscopy — Competitive Intelligence Brief. https://druglandscape.com/ci/bronchial-fibroscopy. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing